Fig. 1: Cumulative excess death rate and incidence rate ratio of PASC in COVID-19 groups by care setting of the acute phase.
From: Three-year outcomes of post-acute sequelae of COVID-19
a, The solid lines at the center of shaded bands were adjusted cumulative excess death rate per 1,000 persons in non-hospitalized COVID-19 (n = 114,864) and hospitalized COVID-19 (n = 20,297) groups compared to the control group without infection (n = 5,206,835), and the shaded bands present the 95% CIs for cumulative excess rates. The number at risk, weighted IRR and weighted excess rate per 1,000 persons in the COVID-19 groups by care setting of the acute phase compared to the control group without infection are also presented in the lower panel. b, IRR of overall PASC and by organ system in non-hospitalized COVID-19 group (n = 114,864) compared to the control group without infection (n = 5,206,835). The dots at the center of error bars in both panels represent the adjusted IRRs estimated using the number of post-acute sequelae, and the error bars correspond to the 95% CIs. c, IRR of overall PASC and by organ system in hospitalized COVID-19 group (n = 20,297) compared to the control group without infection (n = 5,206,835). Outcomes are ordered from top to bottom by largest cumulative number of post-acute sequelae at 3 years after infection in the non-hospitalized COVID-19 group. The dots at the center of error bars in both panels represent the adjusted IRRs estimated using the number of post-acute sequelae, and the error bars correspond to the 95% CIs.
